Skip to main content

Want a detailed portfolio tracker?

SELLAS Life Sciences Group (SLS) P/E (2017 - 2026)

SELLAS Life Sciences Group (SLS) P/E from Dec 29, 2017 to Jul 20, 2026. The TTM SELLAS Life Sciences Group (SLS) P/E is -57.63. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of SELLAS Life Sciences Group (SLS)

YearP/EChange
2026-57.63+257.72%
2025-16.11+676.08%
2024-2.08+186.73%
2023-0.72-31.96%
2022-1.06-74.78%
2021-4.22+45.78%
2020-2.89+797.55%
2019-0.32-38.39%
2018-0.52-97.29%
2017-19.31N/A

Comparison SELLAS Life Sciences Group (SLS) P/E with competitors

SELLAS Life Sciences Group (SLS) P/E is -57.63.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.01%
ENLVEnlivex Ltd0.07-100.13%
FGENFibroGen Inc0.24-100.42%
CHRSCoherus Biosciences Inc0.85-101.47%
FBIOFortress Biotech Inc0.95-101.65%
ORMPOramed Pharmaceuticals Inc1.50-102.61%
AGENAgenus Inc3.01-105.22%
INVAInnoviva Inc3.15-105.47%
VXRTVaxart Inc3.55-106.16%
CRMDCorMedix Inc3.63-106.30%
CVACCureVac N.V.4.45-107.71%
GLPGGalapagos NV4.86-108.43%
SRPTSarepta Therapeutics Inc4.88-108.47%
ABEOAbeona Therapeutics Inc5.39-109.35%
ABUSArbutus Biopharma Corp5.60-109.71%
ZVRAZevra Therapeutics Inc5.89-110.21%
SPROSpero Therapeutics Inc6.23-110.81%
CGENCompugen Ltd6.31-110.95%
RIGLRigel Pharmaceuticals6.87-111.92%
SLXNSilexion Therapeutics Corp7.30-112.66%
OMEROmeros Corporation9.26-116.06%
AUPHAurinia Pharmaceuticals Inc9.58-116.63%
PLXProtalix BioTherapeutics Inc10.89-118.90%
ACADAcadia Pharmaceuticals Inc11.73-120.35%
TBPHTheravance Biopharma Inc12.26-121.28%
ADMAAdma Biologics Inc12.42-121.55%
HRMYHarmony Biosciences Holdings Inc13.82-123.98%
SABSSAB Biotherapeutics Inc14.14-124.53%
NAGENiagen Bioscience Inc14.82-125.71%
INCYIncyte Corp15.82-127.45%
REGNRegeneron Pharmaceuticals Inc15.86-127.51%
PBYIPuma Biotechnology Inc17.32-130.04%
CPRXCatalyst Pharmaceuticals Inc17.44-130.26%
EXELExelixis Inc17.54-130.43%
TGTXTG Therapeutics Inc18.97-132.91%
MDXGMimedx Group Inc20.55-135.66%
XOMAXOMA Royalty Corp22.87-139.69%
ARGXArgen X SE24.30-142.16%
CTMXCytomX Therapeutics Inc24.82-143.07%
XOMAOXOMA Royalty Corp25.34-143.98%
HALOHalozyme Therapeutics Inc25.62-144.46%
XOMAPXOMA Royalty Corp25.67-144.54%
VRTXVertex Pharmaceuticals Inc27.99-148.57%
RPRXRoyalty Pharma plc - Class A28.69-149.78%
ASNDAscendis Pharma A/S30.09-152.20%
LGNDLigand Pharmaceuticals Inc - Class B37.91-165.78%
APLSApellis Pharmaceuticals Inc39.02-167.71%
BMRNBiomarin Pharmaceutical Inc42.21-173.24%
KRYSKrystal Biotech Inc45.34-178.68%
ONCBeiGene Ltd69.54-220.66%
PHARPharming Group N.V.75.03-230.18%
TECHBio-Techne Corp101.96-276.91%
VCELVericel Corp109.92-290.72%
ALNYAlnylam Pharmaceuticals Inc117.96-304.68%
GMABGenmab140.29-343.42%
TLXTelix Pharmaceuticals Ltd162.15-381.35%
CORTCorcept Therapeutics Inc212.86-469.33%